{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:20:51Z","timestamp":1781324451538,"version":"3.54.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anndiagpath.2021.151800","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T04:39:22Z","timestamp":1626928762000},"page":"151800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Novel fusion sarcomas including targetable NTRK and ALK"],"prefix":"10.1016","volume":"54","author":[{"given":"Tiane","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan C.","family":"Dougher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Flemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fanburg-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2021.151800_bb0005","first-page":"3655","article-title":"Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation","volume":"53","author":"Bonin","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/PAS.0000000000001203","article-title":"Expanding the spectrum of pediatric NTRK -rearranged mesenchymal tumors","volume":"43","author":"Davis","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0015","doi-asserted-by":"crossref","first-page":"11645","DOI":"10.1093\/nar\/gkaa919","article-title":"TPR is required for the efficient nuclear export of mRNAs and lncRNAs from short and intron-poor genes","volume":"48","author":"Lee","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896920927467","article-title":"A case of Inv(1)(q23q31) TPR-NTRK1 fusion-positive spindle cell neoplasm in an Infant\u2014Uncovered by next-generation sequencing: diagnostic challenge, review, and therapeutic implications","volume":"29","author":"Rekhi","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0000000000000675","article-title":"Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors","volume":"40","author":"Agaram","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/JTO.0000000000000093","article-title":"A novel fusion of TPR and ALK in lung adenocarcinoma","volume":"9","author":"La","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-019-05466-8","article-title":"Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer","volume":"179","author":"Kariri","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12881-020-01143-6","article-title":"KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas","volume":"21","author":"Catic","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0045","first-page":"2312","article-title":"Kank1 and Ki67 expression are associated with poor prognosis in human pulmonary adenocarcinoma","volume":"13","author":"Shen","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0050","first-page":"1","article-title":"KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors","volume":"7","author":"Cui","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21030753","article-title":"NTRK fusions in central nervous system tumors: a rare, but worthy target","volume":"21","author":"Gambella","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/esmoopen-2015-000023","article-title":"NTRK gene fusions as novel targets of cancer therapy across multiple tumour types","volume":"1","author":"Amatu","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","article-title":"Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions","volume":"34","author":"Brcic","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-020-01031-w","article-title":"Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors","volume":"15","author":"Kang","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/gcc.22877","article-title":"Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern","volume":"59","author":"Kao","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0090","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchi\u00f2","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2018.12.006","article-title":"New fusion sarcomas: histopathology and clinical significance of selected entities","volume":"86","author":"Miettinen","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/gcc.22671","article-title":"A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1\/2 genes","volume":"57","author":"Suurmeijer","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0110","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/his.14069","article-title":"NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma","volume":"77","author":"Rabban","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1093526617712639","article-title":"Infantile NTRK-associated mesenchymal tumors","volume":"21","author":"Davis","year":"2018","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12957-021-02237-y","article-title":"Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment","volume":"19","author":"Chen","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/mcs.a003376","article-title":"Refractory and metastatic infantile fibrosarcoma harboring LMNA\u2013NTRK1 fusion shows complete and durable response to crizotinib","volume":"5","author":"Bender","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/his.13666","article-title":"Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics","volume":"73","author":"Hung","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOH.0b013e32834521c8","article-title":"Stress erythropoiesis: new signals and new stress progenitor cells","volume":"18","author":"Paulson","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00101","article-title":"Durable clinical response to larotrectinib in an adolescent patient with an undifferentiated sarcoma harboring an STRN - NTRK2 fusion","author":"Wu","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0150","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)65732-X","article-title":"Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma","volume":"153","author":"Rubin","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.22846","article-title":"Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria","volume":"59","author":"Antonescu","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0175","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a001115","article-title":"ALK: a tyrosine kinase target for cancer therapy","volume":"3","author":"Holla","year":"2017","journal-title":"Mol Case Stud"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0180","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/pbc.25424","article-title":"FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor Kazutaka","volume":"62","author":"Ouchi","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-016-0586-z","article-title":"Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report","volume":"11","author":"Tateishi","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1","volume":"41","author":"Haimes","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0195","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1158\/1535-7163.MCT-19-0105","article-title":"Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes","volume":"18","author":"Cou\u00ebtoux du Tertre","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0200","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cup.13926","article-title":"Spindle cell tumor with CD34 and S100 co-expression and distinctive stromal and perivascular hyalinization showing EML4-ALK fusion","volume":"48","author":"Abs","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/gcc.22844","article-title":"Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization","volume":"59","author":"Lopez-Nunez","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/1541-7786.MCR-18-1075","article-title":"Discovery and characterization of recurrent, targetable ALK fusions in leiomyosarcoma","volume":"17","author":"Davis","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0220","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.4836","article-title":"ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma","volume":"241","author":"Lee","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0225","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.3880352","article-title":"ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor","volume":"14","author":"Coffin","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0160-2","article-title":"STUMP un\"stumped\": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion","volume":"8","author":"Subbiah","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","article-title":"ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours","volume":"69","author":"Yamamoto","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear alk","volume":"35","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0250","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.1038\/s41598-017-12679-8","article-title":"Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches","volume":"7","author":"Vendrell","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0255","doi-asserted-by":"crossref","first-page":"iii4","DOI":"10.1093\/annonc\/mdw301","article-title":"The role of the ALK receptor in cancer biology","volume":"27","author":"Hallberg","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0260","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0265","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PAS.0000000000000387","article-title":"Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions","volume":"39","author":"Yeh","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0270","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/ncomms4116","article-title":"Kinase fusions are frequent in Spitz tumours and spitzoid melanomas","volume":"5","author":"Wiesner","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAS.0000000000000761","article-title":"A comparison of morphologic and molecular features of BRAF, ALK, and NTRK1 fusion spitzoid neoplasms","volume":"41","author":"Amin","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0280","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","article-title":"Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas","volume":"10","author":"Guerreiro Stucklin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0285","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/PAS.0000000000000368","article-title":"A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma","volume":"39","author":"Chou","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2020.09.004","article-title":"Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas","volume":"106","author":"Nozaki","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0295","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0300","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddl136","article-title":"Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation","volume":"15","author":"Kawamura-Saito","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0305","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/gcc.22172","article-title":"Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities","volume":"53","author":"Specht","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0310","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/gcc.22454","article-title":"ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements","volume":"56","author":"Kao","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0315","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/dc.23520","article-title":"A case report of CIC-rearranged undifferentiated small round cell sarcoma in the cerebrum","volume":"44","author":"Ito","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/gcc.20945","article-title":"High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas","volume":"51","author":"Italiano","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0325","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/his.12985","article-title":"CIC\u2013DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases","volume":"69","author":"Gambarotti","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0330","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/his.13252","article-title":"CIC break-apart fluorescence in-situ hybridization misses a subset of CIC\u2013DUX4 sarcomas: a clinicopathological and molecular study","volume":"71","author":"Yoshida","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00428-017-2072-8","article-title":"Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes","volume":"470","author":"Yamada","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0340","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PAS.0000000000001187","article-title":"Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas","volume":"43","author":"Le Loarer","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0345","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.humpath.2017.01.012","article-title":"NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma","volume":"65","author":"Sugita","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0355","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000000286","article-title":"A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma","volume":"38","author":"Sugita","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0360","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/PAS.0000000000000335","article-title":"Clinicopathologic features of a second patient with Ewing-like sarcoma harboring CIC-FOXO4 gene fusion","volume":"38","author":"Solomon","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0365","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PAS.0000000000000582","article-title":"Recurrent CIC gene abnormalities in angiosarcomas: a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations","volume":"40","author":"Huang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.598970","article-title":"Case report: a unique case of pediatric central nervous system embryonal tumor harboring the CIC-LEUTX fusion, germline NBN variant and somatic TSC2 mutation: expanding the spectrum of CIC-rearranged neoplasia","volume":"10","author":"Hu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0375","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00401-021-02278-3","article-title":"A novel ATXN1-DUX4 fusion expands the spectrum of \u201cCIC-rearranged sarcoma\u201d of the CNS to include non-CIC alterations","volume":"141","author":"Pratt","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0380","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/0008-5472.CAN-16-3351","article-title":"CIC-DUX4 induces small round cell sarcomas distinct from Ewing sarcoma","volume":"77","author":"Yoshimoto","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0385","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ng.1107","article-title":"A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion","volume":"44","author":"Pierron","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0390","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/PAS.0000000000000223","article-title":"BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma","volume":"38","author":"Puls","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0395","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/pbc.25210","article-title":"Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Soci\u00e9t\u00e9 Fran\u00e7aise des cancers de L\u2019Enfant","volume":"61","author":"Cohen-Gogo","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/modpathol.2014.139","article-title":"BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children","volume":"28","author":"Peters","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0405","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/pin.12319","article-title":"Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: a clinicopathological report of three pediatric cases","volume":"65","author":"Shibayama","year":"2015","journal-title":"Pathol Int"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0410","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1093526617698263","article-title":"BCOR-CCNB3 undifferentiated sarcoma-does immunohistochemistry help in the identification?","volume":"20","author":"Ludwig","year":"2017","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0415","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0000000000000591","article-title":"Novel BCOR-MAML3 and ZC3H7B-BCOR gene fusions in undifferentiated small blue round cell sarcomas","volume":"40","author":"Specht","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0420","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ygyno.2020.02.024","article-title":"Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss","volume":"157","author":"Lin","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0425","first-page":"1669","volume":"33","author":"Antonescu","year":"2020","journal-title":"Clinicopathologic and Molecular Study"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0430","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/PAS.0000000000000926","article-title":"Primary renal sarcomas with BCOR-CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0435","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/PAS.0000000000000629","article-title":"Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney","volume":"40","author":"Kao","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms9891","article-title":"Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney","volume":"6","author":"Roy","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0445","doi-asserted-by":"crossref","first-page":"40934","DOI":"10.18632\/oncotarget.5882","article-title":"Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney","volume":"6","author":"Astolfi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0450","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1159\/000502227","article-title":"Neonatal soft tissue sarcoma with YWHAE-NUTM2B fusion","volume":"12","author":"Guizard","year":"2019","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0455","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.2012.83","article-title":"Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model","volume":"25","author":"Demicco","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0460","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Brief communications fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0465","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0470","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-013-1117-6","article-title":"Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein","volume":"125","author":"Schweizer","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0475","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humpath.2010.05.021","article-title":"Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases","volume":"42","author":"Furusato","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0480","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2020.12.015","article-title":"Gene expression in solitary fibrous tumors (SFTs) correlates with anatomic localization and NAB2-STAT6 gene fusion variants","volume":"191","author":"Bieg","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151800_bb0485","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:34:30Z","timestamp":1761078870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":97,"alternative-id":["S1092913421001003"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151800","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel fusion sarcomas including targetable NTRK and ALK","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151800"}}